MBRX Message Board Post 10862244 | Moleculin Biotech Inc.
home / stock / mbrx / mbrx message board
(investorshangout)
Posted on: Dec/15/2022 15:30:46
Source: investorshangout
https://investorshangout.com/post/view?id=6511332
whytestocks: $MBRX News Article - Moleculin Reports 80% Overall Response Rate in Final Cohort of Phase 1 Single A
News, Short Squeeze, Breakout and More Instantly...
-
Moleculin to Host Virtual AML Clinical Day Featuring Internationally Renowned Clinician, Martin S. Tallman, MD, on May 7, 2024 PR Newswire Live video webcast roundtable with members from the Moleculin Management Team and Dr. Tallman to discuss the unmet medical needs in the ...
-
Moleculin Announces Formation of Scientific Advisory Board to Support Development of Annamycin PR Newswire – Company appoints internationally renowned clinician, Martin S. Tallman , MD as inaugural clinician member HOUSTON , May 1, 2024 /PRNewswire/ --...
-
Moleculin CEO, Walter Klemp highlights Annamycin differentiation in the current AML treatment landscape and potential opportunity FRENCHTOWN, NJ / ACCESSWIRE / April 25, 2024 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today released a Vir...